Wang Zhen said this, of course, not in a false manner, because after a meeting and research, if it is said that the special drug this time has really been developed.

Chen Kejin will be vigorously trained by the medical research base.

Of course, material rewards are only the most basic rewards.

"I declare that this is the end of today's press conference, and if you have any questions, you can let Professor Chen Kejin answer them. ”

After Wang Zhen finished speaking, he left with the other high-level executives one after another.

Seeing that Wang Zhen was busy with official business, Doctor Wang went to the laboratory to conduct his own research under the pretext of going to the laboratory.

Then Wang Zhen and other senior executives held a small meeting.

This meeting was attended only by their senior management, and the purpose was to discuss the incident.

It's like an internal discussion to discuss, for example, the plan for a clinical trial......

There are a total of seven high-level executives in the medical research base, all of whom are of course the founders of the Shuguang medical research base.

They were all very happy to sit around and discuss this incident, because they saw the development process of this No. 13 special drug with their eyes and experience.

It does have a very high chance of success.

Once it really passes the clinical trial, then the biggest benefit is not only Chen Kejin and his team.

It is their seven high-level executives, and these seven high-level executives control as much as 90 percent of the shares of the medical research base.

Because after so many years of development, Shuguang is actually a trademark.

Shuguang Hospital, Shuguang Medical Research Base, Shuguang Pharmaceutical, these are theirs.

Moreover, there is also the Shuguang Hospital, which is a private hospital established by experts and professors from the Shuguang Medical Research Base.

They are classified into the Dawning system, and these hospitals have the priority of Dawning Pharmaceutical.

Shuguang Group is a listed group enterprise, and Wang Zhen is one of the senior executives.

Now Shuguang Group is already the world's leading star enterprise.

Energetic and charismatic, the company's valuation is rising every moment.

If the special drug is really developed this time, then the valuation of Shuguang Group will definitely soar.

The seven high-level executives here are all beneficiaries of this, and it is very normal for them to be happy.

"Wang Zhen, tell me what to do about clinical trials? After we spread the news that we had hired volunteers for a lot of money, it caused a storm. ”

There is even a rumor on the Internet that three million equals one life. ”

The one who spoke was Chen Fuqiang, one of the top executives of the Shuguang Group.

As soon as he said it, the face of the person next to him was a little ugly, because the opinions on the Internet on this matter were very different.

On the one hand, people think that this is reasonable, and on the other hand, they think that it is purely an experiment with human life.

That's why they've been experimenting abroad before, because there's not such a big prejudice against this abroad.

"I think we try to ignore these things, and the most important thing for us now is to ensure that the clinical trial runs smoothly. ”

"There is absolutely no room for error in this clinical trial, and all patients must be as safe as possible to ensure their lives. ”

Wang Zhenyi said, and the others nodded solemnly.

Human life is more important than anything else, and they naturally understand this truth.

In this way, one work by one was decided under discussion.

I thought that there would be very few volunteers who came to participate in this clinical trial, and they would all be affected by online rumors.

But unexpectedly, in just three days, more than 500 people have signed up.

Wang Zhen: They selected a part of the volunteers at each stage.

For example, the age division, or the severity of the disease, etc.

After discussing with the volunteers, Wang Zhen found out that their families were in a state of poverty.

They came to join, in fact, for the sake of heavy money.

Naturally, I came here to get cured, but if I couldn't get cured, I would at least have a lot of money.

The money can leave a guarantee for their loved ones.

Wang Zhen understands this kind of thinking in his heart, and he has mixed feelings in his heart.

In fact, they have set up their own foundations, but it is not enough to help everyone by relying on their own strength.

This made Wang Zhen even more determined that Shuguang Group wanted to set up such a project as a group foundation.

A charity project dedicated to these poor people.

Originally, Wang Zhenyan's plan was to complete this matter within two weeks.

But at this current pace, I'm afraid it won't take two weeks, and one week should be enough.

In just one week, 2,000 words of volunteers applied to join the clinical trial.

In the end, they selected 1,000 people to volunteer for the clinical trial.

Another 1,000 people applied for 10,000 yuan each, which is equivalent to consolation money.

Then the clinical trial was immediately opened, and the special drugs produced by the Shuguang Medical Research Base were applied to these people.

In just two weeks, Wang Zhen and others are closely watching the progress of this clinical trial.

It's not just them, the eyes of the world are here.

Thankfully, the report from the clinical trial came out two weeks later.

Among the 1,000 patients, 500 are critically ill, 300 are intermediate, and 200 are mild.

All patients with mild symptoms have recovered, and the side effects of special drugs and other drugs are minimal.

In the middle stage, the effect of the patient after taking a course of treatment is significantly better, and the condition gradually improves.

The fatality rate of severe patients reached 3 percent, and the rest of the severely ill patients got better after two courses of treatment.

It is estimated that after taking four courses of treatment, the condition will change to this intermediate stage.

When this result came into Wang Zhen's hands, everyone was excited.

Because this shows that the clinical trial was a complete success, fifteen critically ill patients died.

That's because these fifteen critically ill patients have other diseases in them.

The side effects of taking special drugs can lead to other diseases, which can lead to death.

Wang Zhen immediately arranged to hold a second press conference.

The news of the successful development of this special drug will be announced.

At the same time, Wang Zhen arranged for the condolence money to be distributed for the clinical trial as soon as possible.

And a subset of patients should be selected to attend the press conference to show the rest of the news media that they are truly cured.

For Wang Zhen's request, no one will not agree.

This time, they were not only cured of a serious illness for free, but also received a condolence payment of 500,000 yuan.

This is a good thing that fell from the sky, and I am very grateful to Wang Zhen for the Shuguang Medical Research Base.

When the news of the successful clinical trial and the successful development of a special drug came, the whole country was boiling and the world was in an uproar.

This great project was thus successfully completed.

The seven high-level officials in the conference room in the Shuguang Medical Research Base gathered together at this time.

Strict planning has been made for the production and sales of No. 13 special drug in the future.

And the No. 13 special drug was named the gram gold special drug.

Named after Chen Kejin to illustrate his status.

Chen Kejin's status has risen sharply with the success of the development of Kejin's special drugs.

In the Dawning Medical Research Base, it is now equivalent to a big man.

For a time, the news of the special drug developed by Chen Kejin was full of news.

Everyone is investigating what happened to this cowman who suddenly appeared out of thin air?

Then I saw his resume, not that he really didn't have a little identity.

It's that his identity is not as prominent as Wang Zhen, even if his identity is not as prominent as Wang Zhen now, it may not be possible in the future.

When the news came that the Shuguang Medical Research Base was going to hold a second press conference.

All the news outlets flocked to it, and almost all the media outlets across the country came over.

Foreign media also had reporters here, so almost all of them were blocked at the press conference.

They all want to be in the best position to be able to ask a question.

And this time, Wang Zhen and the others chose to let Chen Kejin tell about his development process.

His research idea, No. 13 special drug has now obtained a patent.

This patent belongs to Chen Kejin, not to the Shuguang Medical Research Base.

But the Dawning Medical Research Base needs eighty percent of the drug's net profit.

The other two percent are Chen Kejin's, this is the rule.

Otherwise, how could the Shuguang Medical Research Base have so much money for researching drugs?

Every year, it is 100 projects, nearly 40 billion yuan.

How did this money come from, of course, it was earned from the drugs produced.

Shuguang Medical Research Base has always advocated striving for people's health and creating affordable drugs.

The net profit of the drugs they produce will not be high, so that ordinary people can eat affordable drugs.